Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia

• Published in: Blood advances Vol. 1; no. 3; pp. 160 - 169
• Main Authors: Kinstrie, Ross, Karamitros, Dimitris, Goardon, Nicolas, Morrison, Heather, Hamblin, Mike, Robinson, Lisa, Clark, Richard E., Copland, Mhairi, Vyas, Paresh
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 27.12.2016; American Society of Hematology; Elsevier
• Subjects: Myeloid Neoplasia
• ISSN: 2473-9529; 2473-9537
• DOI: 10.1182/bloodadvances.2016000810

Chronic myeloid leukemia (CML) is an excellent model of the multistep processes in cancer. Initiating BCR-ABL mutations are required for the initial phase of the disease (chronic phase, CP-CML). Some CP-CML patients acquire additional mutation(s) that transforms CP-CML to poor prognosis, hard to treat, acute myeloid or lymphoid leukemia or blast phase CML (BP-CML). It is unclear where in the hemopoietic hierarchy additional mutations are acquired in BP-CML, how the hemopoietic hierarchy is altered as a consequence, and the cellular identity of the resulting leukemia-propagating stem cell (LSC) populations. Here, we show that myeloid BP-CML is associated with expanded populations that have the immunophenotype of normal progenitor populations that vary between patients. Serial transplantation in immunodeficient mice demonstrated functional LSCs reside in multiple populations with the immunophenotype of normal progenitor as well as stem cells. Multicolor fluorescence in situ hybridization detected serial acquisition of cytogenetic abnormalities of chromosome 17, associated with transformation to BP-CML, that is detected with equal frequency in all functional LSC compartments. New effective myeloid BP-CML therapies will likely have to target all these LSC populations. •In BP-CML multiple, nonhierarchically arranged immunophenotypic stem/progenitor populations have functional LSC activity.•BP-associated cytogenetic abnormalities are detected equally in all immunophenotypic stem/progenitor cells.